Twist Bioscience Status
The company raised $86 million in its initial public offering on the Nasdaq stock exchange under the ticker symbol of TWST on November 1, 2018. A total of 5,000,000 shares were sold at $14 per share. After the offering, there was a total of 26,609,991 outstanding shares (excluding the over-allotment option) priced at $14 per share, valuing the company at $372.54 million. The underwriters were granted an option to purchase up to an additional 750,000 shares from the company to cover over-allotments, if any.